Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Poliomyelitis eradication.

W R Dowdle1, D A Featherstone, M E Birmingham

  • 1The Task Force for Child Survival and Development, Decatur, GA 30030, USA.

Virus Research
|October 3, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A New Method for Estimating the Coverage of Mass Vaccination Campaigns Against Poliomyelitis From Surveillance Data.

American journal of epidemiology·2015
Same author

Integration, community engagement, and polio eradication in Nigeria - authors' reply.

The Lancet. Global health·2014
Same author

[Evaluation of the commercial ELISA test-systems of different formats to detect specific IgM and IgG in the measles patients sera].

Voprosy virusologii·2014
Same author

[Peculiarity of the laboratory diagnostic of the measles virus infection in previously vaccinated and unvaccinated patients].

Voprosy virusologii·2012
Same author

Molecular epidemiology of measles virus.

Current topics in microbiology and immunology·2009
Same author

Mass vaccination: when and why.

Current topics in microbiology and immunology·2006
Same journal

Vaccination with an HSV-1 virus containing CD-137L reduces herpetic corneal disease when used both prophylactically and therapeutically.

Virus research·2026
Same journal

Ondansetron exhibits potent antiviral activity against enterovirus 71 infection in vitro and in vivo.

Virus research·2026
Same journal

Case report: A case of HIV seroconversion in a high-risk individual after 35 years of resistance with a CCR5Δ32 heterozygous genotype.

Virus research·2026
Same journal

Viruses under mechanical force: Implications and applications.

Virus research·2026
Same journal

Mechanisms and therapeutic implications of galectins regulating Epstein-Barr virus infection.

Virus research·2026
Same journal

Functional SLC29A3/ENT3 drives autophagic clearance of intracellular viral particles.

Virus research·2026
See all related articles

Global polio cases have significantly decreased since 1988, nearing eradication. Challenges persist in specific regions, and strategies for stopping oral polio vaccine (OPV) use are under discussion.

Area of Science:

  • Global Health
  • Infectious Disease Epidemiology
  • Vaccinology

Background:

  • The Global Polio Eradication Initiative, launched in 1988, has dramatically reduced poliovirus incidence worldwide.
  • Polio incidence has decreased by nearly 90%, with a corresponding reduction in poliovirus genomic diversity.

Purpose of the Study:

  • To summarize the progress and remaining challenges in polio eradication.
  • To outline the key considerations for post-eradication strategies, including vaccine cessation and virus containment.

Main Methods:

  • Review of global polio incidence data and epidemiological trends.
  • Analysis of factors contributing to eradication challenges in endemic regions.
  • Examination of proposed strategies for wild poliovirus containment and oral polio vaccine (OPV) cessation.

Related Experiment Videos

Main Results:

  • Polio is now endemic in only two continents and 53 countries, down from five continents and over 100 countries.
  • Major obstacles to eradication include socio-economic factors, climate, population density, and health infrastructure in South Asia and Africa.
  • The World Health Organization (WHO) is developing plans for wild poliovirus containment and certification of eradication.

Conclusions:

  • While significant progress has been made, polio eradication faces persistent challenges in specific high-risk areas.
  • Post-eradication planning is crucial, focusing on vaccine-derived poliovirus surveillance and the eventual cessation of oral polio vaccine (OPV) immunization.
  • Further research is needed to assess the risks of continued circulation of vaccine-derived polioviruses after OPV cessation.